Drimva

NewLimit

Scientist/Senior Scientist

$130K–$180K

South San Francisco, CA +1 · Senior · Full-time · Posted Sep 17, 2025

Location
South San Francisco, CA
South San Francisco, California, United States
Experience
5+ years of equivalent industry experience; alternatively, a Ph.D. is requested.
Education
Ph.D. in cell biology, molecular biology, biochemistry or a related field, or equivalent industry experience.

About the job

Develops assays and pre-clinical models to measure age-related endothelial cell decline and evaluates reprogramming medicines for vascular applications.

What you'll do

  • Develop functional assays and pre-clinical models for endothelial cell function; analyze results to inform pre-clinical decisions.
  • Collaborate with Functional Genomics and Predictive Modeling teams to test reprogramming hypotheses at scale.
  • Measure the effects of mRNA reprogramming medicines and engineer in vivo nucleic acid delivery methods for endothelial cells.

What they ask for

  • Ph.D. in cell biology, molecular biology, biochemistry or a related field, or equivalent industry experience (5+ years).
  • Experience with primary cell isolation and functional characterization.
  • Experience working with mouse models, such as kidney, cardiovascular, or cognitive disease models.
  • Experience with transgenic manipulation of primary cells ex vivo or in vivo, such as using viral vectors or nucleic acid delivery.

Nice to have

  • History of contributing to a drug development program at the pre-clinical or clinical development stage.
  • Experience leading pre-clinical mouse studies, single cell genomics, or pooled screening approaches.

Pay

$130,000 to $180,000 USD base salary

Tools

mRNA, viral vectors, nucleic acid delivery, single cell genomics, CRISPR fitness screens, Perturb/CROP-seq

AI focus

The role collaborates with Predictive Modeling and Functional Genomics teams to test reprogramming hypotheses at scale; the posting also describes the company’s use of machine learning models.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)